GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 19 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 19 | -52.5% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 40 | -16.7% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 48 | +20.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -84.6% | 40 | -87.3% | 0.00% | -100.0% |
| Q4 2018 | $13,000 | -99.8% | 315 | +129.9% | 0.00% | 0.0% |
| Q2 2018 | $6,193,000 | +19253.1% | 137 | -79.0% | 0.00% | -66.7% |
| Q1 2018 | $32,000 | +700.0% | 653 | +573.2% | 0.00% | – |
| Q4 2017 | $4,000 | +100.0% | 97 | +59.0% | 0.00% | – |
| Q3 2017 | $2,000 | -66.7% | 61 | -70.2% | 0.00% | -100.0% |
| Q2 2017 | $6,000 | +20.0% | 205 | +40.4% | 0.00% | – |
| Q1 2017 | $5,000 | -44.4% | 146 | -77.0% | 0.00% | -100.0% |
| Q4 2016 | $9,000 | – | 636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |